|
Thursday November 13, 2008
|
|
|
XIV European Charcot Lecture
|
|
|
The natural history of Multiple Sclerosis and Gender.
|
Dessa Sadovnick
|
|
|
|
|
Epidemiology
|
|
|
|
|
|
Gender related immuno-inflammatory factors and human disease.
|
Giuseppina Candore
|
|
Clustering of Multiple Sclerosis, age of onset and gender in
Sardinia.
|
Maura Pugliatti
|
|
Increasing incidence of Multiple Sclerosis in women in
Lorraine (
France).
|
Marc Debouverie
|
|
Increase and incidence of Multiple Sclerosis in women; data from the Danish Multiple Sclerosis Registry.
|
Per Soelberg SØrensen
|
|
|
|
|
|
|
|
Friday November 14, 2008
|
|
|
|
|
|
Life style changes and demographic patterns of Multiple Sclerosis.
|
George Ebers
|
|
Disease evolution and gender.
|
Gilles Edan
|
|
Neuromyelitis optica (Devic). What is the role of gender?
|
Dean Wingerchuk
|
|
Pregnancy and Multiple Sclerosis.
|
Judith Haas
|
|
Leber’s disease and gender.
|
Jackie
Palace
|
|
Gender differences in MRI, studies on Multiple Sclerosis.
|
Frans Fazekas
|
|
Early onset Multiple Sclerosis. The role of gender.
|
Mar Tintoré
|
|
Sex hormones, brain damage and the clinical course of Multiple Sclerosis.
|
Valentina Tomassini
|
|
Sex differences in pro-inflammatory cytokines.
|
Judith Eikelenboom
|
|
|
|
|
Genetics
|
|
|
|
|
|
Gender-bias in auto-immune diseases. X-chromosome inactivation in women with Multiple Sclerosis.
|
Gun Peggy Knudsen
|
|
Gene expression in relation to gender in MS.
|
Anat Achiron
|
|
|
|
|
Environmental factors and gender
|
|
|
|
|
|
Environmental factors in Multiple Sclerosis.
|
Stuart Cook
|
|
Time of exposure of environmental factors in Multiple Sclerosis.
|
George Ebers
|
|
Women’s life style and Multiple Sclerosis.
|
Judith Haas
|
|
Manipulation of environment and factors in Multiple Sclerosis. The
Martinique experience.
|
Philippe Cabre
|
|
EBV and Multiple Sclerosis.
|
Daniela Pohl
|
|
The triggering role of Herpes viridae in Multiple Sclerosis.
|
Hervé Perron
|
|
Oral contraceptives and the risk of Multiple Sclerosis.
|
Alvaro Alonso
|
|
|
|
|
Saturday November 15, 2008
|
|
|
|
|
|
Experimental Mechanisms
|
|
|
|
|
|
Sexual dimorphism in the white matter of rodents.
|
Mirela Cerghet
|
|
Neuro-protective and anti-inflammatory effects of estrogen receptors ligand treatment in mice.
|
Seema Tiwara Woodruff
|
|
White matter plasticity and enhanced remyelination in maternal CNS of mice.
|
|
Christopher Gregg
|
|
Pathology
|
|
|
|
|
|
Gender differences in de- and remyelination in Multiple Sclerosis.
|
Tanja Kuhlmann
|
|
|
|
|
Treatment
|
|
|
|
|
|
Are there gender effects in disease modifying treatments?
|
Giancarlo Comi
|
|
Glatiramer Acetate treatment in primary progressive Multiple Sclerosis. Why males appear to respond favourably.
|
Jerry Wolinsky
|
|
Estriol treatment in Multiple Sclerosis.
|
Rhonda Voskuhl
|
|
Vitamin D treatment in Multiple Sclerosis.
|
Speaker invited
|
|
Post marketing of Disease Modifying Drugs. Gender questions.
|
Maria Trojano
|
|
PopartMUS trial, a child of PRIMS.
|
Christian Confavreux
|
|
|
|
|
The Symposium will start on Thursday November 13, 2008 at 2.00 p.m. and will end on Saturday November 15, 2008 around 4.00 p.m.
|
|
|
Satellite Symposia
|
|
|
|
|
|
Thursday November 13, 2008
|
|
|
|
|
|
Novartis Pharma AG (Programme to be announced)
|
11.00 a.m.– 01 .00 p.m.
|
|
Octapharma AG (Programme to be announced)
|
6.00 – 8.00 p.m.
|
